In-clinic RF treatments often require downtime due to redness and soreness, but at-home devices harness lower energy levels, ...

Recently revealed trial results for Roche's experimental weight-management drug suggest Viking Therapeutics is on the right ...

Sorrento Therapeutics faced a financial and legal crisis in February 2023, and needed to file for bankruptcy. The pharmaceutical developer’s chief executive and chief financial officers met with ...

The S&P 500 had its second-worst day of the year to kick off the month of September, with the tech-focused Nasdaq extending its third quarter slump. Though it is likely to be lower than the ...

Finding the best Wi-Fi channel for your 5GHz frequency is crucial for optimizing your network's performance, especially in densely populated areas where interference is common. Here’s a step-by ...

Viking Therapeutics' VK2735, a dual GLP-1/GIP receptor agonist, shows promising results in Phase II trials for obesity treatment with potential for both subcutaneous and oral formulations.

Travere Therapeutics (TVTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Liisa Bayko from Evercore ISI maintained a Buy rating on the ...

We came across a bullish thesis on TG Therapeutics Inc (TGTX) on ValueInvestorsClub by Bohr. In this article we will summarize the bulls' thesis on TGTX. TG Therapeutics shares were trading at $14 ...

TG Therapeutics' Briumvi shows strong revenue growth, with Q2 2024 revenue up 350% YoY, leading to an upgraded full-year guidance of $290-$300 million. Expansion into CAR-T therapy for autoimmune ...

Credit: Panchenko Vladimir/Shutterstock. Navigator Medicines has secured $100m in a Series A financing round jointly led by RA Capital Management and Forbion to advance bispecific antibody ...

This device combines radio frequency with LED therapy–doubling down on promoting the production of collagen and elastin–and sonic massage, which increases blood flow and product absorption for ...